Status:
TERMINATED
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
Lead Sponsor:
Zhi-Hong Liu, M.D.
Conditions:
Polycystic Kidney
Eligibility:
All Genders
15-70 years
Phase:
NA
Brief Summary
Triptolide has been approve effective in animal model.
Detailed Description
Randomized
Eligibility Criteria
Inclusion
- Clinically established ADPKD
- eGFR\>30ml/min.
- Chinese nationality
Exclusion
- Uncontrolled infections
- Non-ADPKD complications
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00801268
Start Date
November 1 2008
End Date
November 1 2013
Last Update
March 30 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Liu ZH, Yao XD,Chen X,Hu YL
Nanjing, Jiangsu, China, 210002
2
Yao Xiaodan
Nanjing, Jiangsu, China, 210002